Jeff Auxier's MDT Position Overview
Jeff Auxier (via Auxier Asset Management LLC) currently holds 138,854 shares of Medtronic plc (MDT) worth $13.34 M, representing 1.88% of the portfolio. First purchased in 2015-Q1, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Jeff Auxier has maintained a long-term strategic position in MDT, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2016, adding 7,800 shares. Largest reduction occurred in Q4 2018, reducing 6,040 shares.
Analysis based on 13F filings available since 2013 Q2
Jeff Auxier's Medtronic plc (MDT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Medtronic plc (MDT) Trades by Jeff Auxier
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1,134 | Reduce 0.81% | 138,854 | $96.06 |
| Q3 2025 | -598 | Reduce 0.43% | 139,988 | $95.24 |
| Q2 2025 | -558 | Reduce 0.40% | 140,586 | $87.17 |
| Q1 2025 | -98 | Reduce 0.07% | 141,144 | $89.86 |
| Q4 2024 | -2,190 | Reduce 1.53% | 141,242 | $79.88 |
| Q3 2024 | -110 | Reduce 0.08% | 143,432 | $90.03 |
| Q2 2024 | -3,598 | Reduce 2.45% | 143,542 | $78.71 |
| Q1 2024 | +153 | Add 0.10% | 147,140 | $87.15 |
| Q4 2023 | -255 | Reduce 0.17% | 146,987 | $82.38 |
| Q3 2023 | -125 | Reduce 0.08% | 147,242 | $78.36 |
| Q2 2023 | +285 | Add 0.19% | 147,367 | $88.10 |
| Q1 2023 | +2,075 | Add 1.43% | 147,082 | $80.62 |
| Q4 2022 | +1,900 | Add 1.33% | 145,007 | $77.72 |
| Q3 2022 | -300 | Reduce 0.21% | 143,107 | $80.75 |
| Q2 2022 | +2,575 | Add 1.83% | 143,407 | $89.75 |
| Q1 2022 | -5 | Reduce 0.00% | 140,832 | $110.95 |
| Q4 2021 | -185 | Reduce 0.13% | 140,837 | $103.45 |
| Q3 2021 | -915 | Reduce 0.64% | 141,022 | $125.35 |
| Q2 2021 | -1,645 | Reduce 1.15% | 141,937 | $124.13 |
| Q1 2021 | -300 | Reduce 0.21% | 143,582 | $118.13 |
| Q4 2020 | -133 | Reduce 0.09% | 143,882 | $117.14 |
| Q3 2020 | -65 | Reduce 0.05% | 144,015 | $103.92 |
| Q2 2020 | -225 | Reduce 0.16% | 144,080 | $91.70 |
| Q1 2020 | -413 | Reduce 0.29% | 144,305 | $90.18 |
| Q4 2019 | -185 | Reduce 0.13% | 144,718 | $113.45 |
| Q3 2019 | -3,645 | Reduce 2.45% | 144,903 | $108.62 |
| Q2 2019 | -2,325 | Reduce 1.54% | 148,548 | $97.39 |
| Q1 2019 | -285 | Reduce 0.19% | 150,873 | $91.08 |
| Q4 2018 | -6,040 | Reduce 3.84% | 151,158 | $90.96 |
| Q3 2018 | -1,900 | Reduce 1.19% | 157,198 | $98.37 |
| Q2 2018 | -2,150 | Reduce 1.33% | 159,098 | $85.61 |
| Q1 2018 | +5,915 | Add 3.81% | 161,248 | $80.22 |
| Q4 2017 | +7,085 | Add 4.78% | 155,333 | $80.75 |
| Q3 2017 | +1,250 | Add 0.85% | 148,248 | $77.77 |
| Q2 2017 | -25 | Reduce 0.02% | 146,998 | $88.75 |
| Q1 2017 | +100 | Add 0.07% | 147,023 | $80.56 |
| Q4 2016 | +7,800 | Add 5.61% | 146,923 | $71.23 |
| Q3 2016 | -50 | Reduce 0.04% | 139,123 | $86.40 |
| Q2 2016 | -600 | Reduce 0.43% | 139,173 | $86.77 |
| Q1 2016 | +500 | Add 0.36% | 139,773 | $75.00 |
| Q4 2015 | -200 | Reduce 0.14% | 139,273 | $76.92 |
| Q3 2015 | -110 | Reduce 0.08% | 139,473 | $66.94 |
| Q2 2015 | -500 | Reduce 0.36% | 139,583 | $74.10 |
| Q1 2015 | +140,083 | New Buy | 140,083 | $77.99 |
Jeff Auxier's Medtronic plc Investment FAQs
Jeff Auxier first purchased Medtronic plc (MDT) in Q1 2015, acquiring 140,083 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jeff Auxier has held Medtronic plc (MDT) for 44 quarters since Q1 2015.
Jeff Auxier's largest addition to Medtronic plc (MDT) was in Q1 2015, adding 140,083 shares worth $10.92 M.
According to the latest 13F filing for Q4 2025, Jeff Auxier's firm, Auxier Asset Management LLC, owns 138,854 shares of Medtronic plc (MDT), valued at approximately $13.34 M.
As of the Q4 2025 filing, Medtronic plc (MDT) represents approximately 1.88% of Jeff Auxier's publicly disclosed stock portfolio, making it one of their key holdings.
Jeff Auxier's peak holding in Medtronic plc (MDT) was 161,248 shares, as reported at the end of Q1 2018.